(Q35161738)

6 August 2017

1 reference

title

Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules (English)

1 reference

6 August 2017

4

Saburo Sone

1 reference

6 August 2017

Seiji Yano

1

1 reference

PubMed ID

12824870

6 August 2017

Yasuhiko Nishioka

series ordinal

2

1 reference

PubMed ID

12824870

6 August 2017

Hisatsugu Goto

series ordinal

3

1 reference

6 August 2017

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

94

1 reference

6 August 2017

6

1 reference

6 August 2017

479-485

1 reference

Role of angiogenesis in tumor growth and metastasis

6 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Mechanisms and future directions for angiogenesis-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

The seed and soil hypothesis: vascularisation and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Severe acute interstitial pneumonia and gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01469.X

10.1111/J.1349-7006.2003.TB01469.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12824870